<DOC>
	<DOCNO>NCT01325337</DOCNO>
	<brief_summary>This study evaluate safety efficacy 3 dos bimatoprost solution compare vehicle over-the-counter ( OTC ) minoxidil 5 % solution men androgenic alopecia . All treatment provide double-blinded fashion except minoxidil 5 % solution provide open-label .</brief_summary>
	<brief_title>Safety Efficacy Study Bimatoprost Treatment Men With Androgenic Alopecia</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Minoxidil</mesh_term>
	<criteria>Mild moderate male pattern baldness ( androgenic alopecia ) ongoing hair loss least 1 year Willingness microdottattoo apply scalp Willingness maintain hair style , length hair color study Drug alcohol abuse within 12 month HIV positive Received hair transplant scalp reduction Use hair weave , hair extension wigs within 3 month Oral topical minoxidil treatment within 6 month Application topical steroid nonsteroidal antiinflammatory drug ( NSAIDs ) scalp within 4 week</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>